Home LiteratureArticle Details
PMID: 1100130 Published · ppublish English Clinical Trial Journal Article Research Support, U.S. Gov't, P.H.S.

Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

Biometrics ·Vol. 31 ·No. 1 ·1975-03-00 ·Pages 103-15

Pocock SJ, Simon R

Abstract

In controlled clinical trials there are usually several prognostic factors known or thought to influence the patient's ability to respond to treatment. Therefore, the method of sequential treatment assignment needs to be designed so that treatment balance is simultaneously achieved across all such patients factor. Traditional methods of restricted randomization such as "permuted blocks within strata" prove inadequate once the number of strata, or combinations of factor levels, approaches the sample size. A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor. The improved treatment balance obtained by this approach is explored using simulation for a simple model of a clinical trial. Further discussion centers on the selection, predictability and practicability of such a procedure.

MeSH Terms
Carmustine/therapeutic use Clinical Trials as Topic Cyclophosphamide/therapeutic use Evaluation Studies as Topic Humans Lymphoma/drug therapy,radiotherapy Models, Theoretical Prednisone/therapeutic use Prognosis Statistics as Topic Vincristine/therapeutic use
Chemicals
Vincristine Cyclophosphamide Carmustine Prednisone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Pocock S J
Simon R
Article Info
Journal
Biometrics
Abbr.
Biometrics
ISSN
0006-341X
Published
1975-03-00
Pages
103-15
Language
English
Region
United States
NLM ID
0370625
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com